Jessica Grubb
About Jessica Grubb
Jessica Grubb serves as the Medical Director of Product and Customer Success at Carelon, a position she has held since 2022. With a background that includes roles at Anthem and the National Institutes of Health, she specializes in advocacy product development for complex health conditions.
Work at Carelon
Jessica Grubb serves as the Medical Director for Product and Customer Success at Carelon since 2022. In this role, she is responsible for overseeing product management and ensuring customer satisfaction. She conducts client-facing presentations and leads initiatives that enhance the user experience with Carelon's offerings. Her focus includes the development of advocacy products aimed at addressing complex health conditions.
Previous Experience at Anthem
Before joining Carelon, Jessica Grubb worked at Anthem as a Medical Director from 2016 to 2022. During her six years in this position, she contributed to various healthcare initiatives and strategies in the Charleston, South Carolina area. Her role involved overseeing clinical operations and improving patient care services.
Clinical Fellowship at NIH
Jessica Grubb completed a Clinical Fellowship in Infectious Diseases at the National Institutes of Health from 2003 to 2005. This experience provided her with extensive research exposure and clinical training in a leading medical research institution located in Bethesda, Maryland. Her time at the NIH contributed to her expertise in infectious diseases and advanced her medical knowledge.
Educational Background
Jessica Grubb earned her Bachelor of Arts in Natural Sciences from The Johns Hopkins University. She furthered her education at the University of Maryland, Baltimore, where she obtained her Doctor of Medicine (MD) degree. This educational foundation supports her extensive career in medicine and healthcare.
Advocacy Product Development
Jessica Grubb has a strong background in advocacy product development, particularly for complex health conditions. She has led the clinical development of an Inclusive Care advocacy product, demonstrating her commitment to improving healthcare access and outcomes for patients with intricate health needs.